<i>In vitro</i> activity of cefepime/zidebactam against sulbactam/durlobactam-susceptible and -resistant <i>Acinetobacter baumannii</i> clinical isolates
These results demonstrate that cefepime/zidebactam exhibited potent in vitro antibacterial activity against CRAB producing OXA carbapenemase and support its clinical use against both sulbactam/durlobactam-susceptible or -resistant isolates.
Authors
- Gabriele Bianco (ORCID: https://orcid.org/0000-0002-8180-5075)
- Paolo Gaibani (ORCID: https://orcid.org/0000-0003-3791-8635)
- Carlo Tascini
- Robert A Bonomo
Institutions
- University of Verona (IT)
- University of Udine (IT)
- University of Salento (IT)
- Azienda Ospedaliera Universitaria Integrata Verona (IT)
- Ospedale Santa Maria della Misericordia di Udine (IT)
- Ospedale Vito Fazzi (IT)
- Azienda Sanitaria Universitaria Integrata di Trieste (IT)
- Case Western Reserve University (US)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-12-06
- DOI
- https://doi.org/10.1093/jac/dkaf467
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00